Laila Abdel-Kader Martín-rekin lankidetzan egindako argitalpenak (5)

2022

  1. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    The Lancet, Vol. 399, Núm. 10320, pp. 143-151

  2. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    The Lancet, Vol. 400, Núm. 10349, pp. 359-368

  3. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    The Lancet, Vol. 399, Núm. 10325, pp. 665-676

2021

  1. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    The Lancet, Vol. 397, Núm. 10289, pp. 2049-2059

  2. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    The Lancet, Vol. 397, Núm. 10285, pp. 1637-1645